programas cribado cancer


Nota Bibliográfica

Esta Nota es una recopilación de publicaciones (artículos, informes, libros) sobre cribado de cáncer resultado de una revisión no sistemática de la literatura.

Podéis dirigir vuestros comentarios o sugerencias sobre la Nota a:

Josep A Espinás. Pla Director d'Oncología de Catalunya.
Correo electrónico: Esta dirección electrónica esta protegida contra spam bots. Necesita activar JavaScript para visualizarla

Nota bibliográfica cribado c, miscelánea 2012-11

Hudson B, Zarifeh A, Young L, Wells JE. Patients' expectations of screening and preventive treatments. Ann Fam Med 2012 Nov;10(6):495-502. DOI:10.1370/afm.1407; 10.1370/afm.1407. PMID:23149525.

CONCLUSION Patients overestimated the risk reduction achieved with 4 examples of screening and preventive medications. A lower level of education was associated with higher minimum benefit to justify intervention use. This tendency to overestimate benefits may affect patients' decisions to use such interventions, and practitioners should be aware of this tendency when discussing these interventions with patients.


Nota bibliográfica cribado c miscelánea 2012-10

Segura A. Aspectos éticos sobre el límite de edad de los cribados de cáncer. FMC - Formación Médica Continuada en Atención Primaria 2011 Mar;18(3):125-30.  DOI: doi: 10.1016/S1134-2072(11)70045-7
Woloshin S, Schwartz LM, Black WC, Kramer BS. Cancer Screening Campaigns - Getting Past Uninformative Persuasion. New England Journal of Medicine 2012 Oct 31;367(18):1677-9.  DOI: doi: 10.1056/NEJMp1209407


Nota bibliográfica cribado c miscelánea 2012-09

Deppen SA, Aldrich MC, Hartge P, Berg CD, Colditz GA, Petitti DB, et al. Cancer Screening: The Journey from Epidemiology to Policy. Annals of Epidemiology 2012 Jun;22(6):439-45.  DOI: doi: 10.1016/j.annepidem.2012.03.004
Conclusions In the complex landscape for cancer screening policy, epidemiologists can increase their impact by learning from past experiences, being well prepared and communicating effectively
Hartzband P, Groopman J. There is more to life than death. N Engl J Med 2012 Sep 13;367(11):987-9.  DOI: 10.1056/NEJMp1207052 [doi]  PM:22970943


Nota bibliográfica cribado c miscelánea 2012-07

Rakowski W, Rogers ML, Dominick GM, Clark M. UNDERSTANDING REVERSALS OF ASSOCIATION BETWEEN CANCER SCREENING AND RACE/ETHNICITY . Cancer Epidemiology Biomarkers & Prevention 2012 Jun 26.  DOI: 10.1158/1055-9965.EPI-11-1223
 Conclusions: Results were consistent with the possibility that access-enhancing programs for lower-income, uninsured and often Non-White women can lead to overestimates of screening, RA's and LPCs in multivariable analyses. Attention should be given to identifying large percent changes to unadjusted odds ratios. Lower-income, uninsured White women are also a group at risk of extremely low mammography and Pap test utilization. Impact: Combining variables to create better-targeted population subgroups may help in the interpretation of analyses that produce RAs, and LPCs for correlates of cancer screening utilization
** Rossi PG, Camilloni L, Cogo C, Federici A, Ferroni E, Furnari G, et al. Metodi per aumentare la partecipazione ai programmi di screening oncologici. Epidemiol Prev 2012 Jan;36(1 Suppl 1):1-104.  PM:22418841


Nota bilbiográfica cribado c miscelánea 2012-06

Slomski A. Screening women for ovarian cancer still does more harm than good. JAMA 2012 Jun 20;307(23):2474-5.  DOI: 1187925 [pii];10.1001/jama.2012.5646 [doi]


Página 4 de 8

web desarrollada y mantenida por :